MPLN vs. EEX, TIXT, ETWO, RDWR, YEXT, RSKD, UXIN, IIIV, PRTH, and ADV
Should you be buying MultiPlan stock or one of its competitors? The main competitors of MultiPlan include Emerald (EEX), TELUS International (Cda) (TIXT), E2open Parent (ETWO), Radware (RDWR), Yext (YEXT), Riskified (RSKD), Uxin (UXIN), i3 Verticals (IIIV), Priority Technology (PRTH), and Advantage Solutions (ADV). These companies are all part of the "business services" industry.
MultiPlan vs.
MultiPlan (NYSE:MPLN) and Emerald (NYSE:EEX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends.
87.2% of MultiPlan shares are owned by institutional investors. Comparatively, 14.9% of Emerald shares are owned by institutional investors. 8.0% of MultiPlan shares are owned by company insiders. Comparatively, 11.5% of Emerald shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
MultiPlan presently has a consensus target price of $26.25, suggesting a potential upside of 64.73%. Emerald has a consensus target price of $7.90, suggesting a potential upside of 69.20%. Given Emerald's stronger consensus rating and higher possible upside, analysts plainly believe Emerald is more favorable than MultiPlan.
Emerald has lower revenue, but higher earnings than MultiPlan. Emerald is trading at a lower price-to-earnings ratio than MultiPlan, indicating that it is currently the more affordable of the two stocks.
Emerald received 177 more outperform votes than MultiPlan when rated by MarketBeat users. Likewise, 59.18% of users gave Emerald an outperform vote while only 35.71% of users gave MultiPlan an outperform vote.
In the previous week, Emerald had 1 more articles in the media than MultiPlan. MarketBeat recorded 2 mentions for Emerald and 1 mentions for MultiPlan. MultiPlan's average media sentiment score of 0.59 beat Emerald's score of 0.45 indicating that MultiPlan is being referred to more favorably in the media.
Emerald has a net margin of -5.29% compared to MultiPlan's net margin of -163.30%. MultiPlan's return on equity of -12.14% beat Emerald's return on equity.
MultiPlan has a beta of 0.1, meaning that its share price is 90% less volatile than the S&P 500. Comparatively, Emerald has a beta of 1.44, meaning that its share price is 44% more volatile than the S&P 500.
Summary
Emerald beats MultiPlan on 12 of the 18 factors compared between the two stocks.
Get MultiPlan News Delivered to You Automatically
Sign up to receive the latest news and ratings for MPLN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MultiPlan Competitors List
Related Companies and Tools
This page (NYSE:MPLN) was last updated on 1/20/2025 by MarketBeat.com Staff
